Trailing-twelve-month (TTM) revenue is $5.06 Billion with a year-over-year growth of +11.68%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $1,141,700,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-31 |
| Q4 FY2025Period ended 2025-12-31 | $1,204,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-20 |
| Q1 FY2026Period ended 2026-03-31 | $1,272,800,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-31 |
| Q2 FY2026Period ended 2026-06-30 | $1,442,800,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-31 |
| TTM revenue | $5,061,300,000 |
Current P/S: $27,003,871,620 market capitalization ÷ $5,061,300,000 TTM revenue = 5.34x.
Market capitalization source: FMP quote. Quote observed 2026-09-25T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $1.44B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-26T00:15:34.654Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Access And Capacity Fees | $237M | $281M | N/A | N/A | $370M | $409M |
| Cash and spot markets | N/A | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20252025-12-31 · USD |
|---|---|
| Europe and Asia Pacific | $379M |
| North American Equities | $1.7B |
$5.06B
$5.06 Billion
+11.68%
vs. $4.53B a year ago (TTM)
+7.98%
5 Year compound annual growth rate
1 Year
+11.68%
3 Year
+9.13%
5 Year
+7.98%
10 Year
+22.44%
15 Year
+17.20%
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $4.71B | +$619.70M | +15.13% |
| 2024 | $4.09B | +$321.00M | +8.51% |
| 2023 | $3.77B | ($185.00M) | (4.67%) |
| 2022 | $3.96B | +$463.70M | +13.27% |
| 2021 | $3.49B | +$67.70M | +1.98% |
| 2020 |
TTM Growth
+11.68%
3-Year CAGR
+9.13%
5-Year CAGR
+7.98%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $1.4B |
| N/A |
| N/A |
| Data and access solutions | N/A | N/A | $497M | $539M | N/A | N/A |
|---|
| Derivatives markets | N/A | N/A | $1.7B | $1.8B | N/A | N/A |
|---|
| Liquidity Payments | $1.6B | $1.7B | $1.7B | $1.4B | N/A | N/A |
|---|
| Market Data Fees | $232M | $252M | N/A | N/A | $295M | $327M |
|---|
| Other Revenue | N/A | N/A | N/A | N/A | $99M | $96M |
|---|
| Regulatory Fees | $500M | $208M | N/A | N/A | $426M | $285M |
|---|
| Routing And Clearing | $70M | $88M | $83M | $79M | N/A | N/A |
|---|
| Royalty Fees | $83M | $86M | N/A | N/A | N/A | N/A |
|---|
| Section31 Fees | $465M | $180M | $330M | $186M | N/A | N/A |
|---|
| Transaction And Clearing Fees | N/A | N/A | N/A | N/A | $2.9B | $3.6B |
|---|
| $3.43B |
| +$931.00M |
| +37.30% |
| 2019 | $2.50B | ($272.70M) | (9.85%) |
| 2018 | $2.77B | +$539.70M | +24.21% |
| 2017 | $2.23B | +$1.58B | +245.54% |
| 2016 | $645.11M | +$10.56M | +1.66% |
